RBC
EW icon

Romano Brothers & Co’s Edwards Lifesciences EW Stock Holding History

Romano Brothers & Co’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$507K Hold
5,605
– – 0.05% 238
2026
Q1 		$449K Hold
5,605
– – 0.05% 241
2025
Q4 		$478K Hold
5,605
– – 0.05% 228
2025
Q3 		$436K Sell
5,605
-567
-9% -$44.3K 0.05% 235
2025
Q2 		$483K Hold
6,172
– – 0.06% 220
2025
Q1 		$447K Hold
6,172
– – 0.06% 223
2024
Q4 		$457K Sell
6,172
-50
-0.8% -$3.5K 0.06% 218
2024
Q3 		$411K Hold
6,222
– – 0.05% 229
2024
Q2 		$575K Sell
6,222
-195
-3% -$17.3K 0.08% 196
2024
Q1 		$613K Sell
6,417
-120
-2% -$10.1K 0.08% 188
2023
Q4 		$498K Hold
6,537
– – 0.07% 198
2023
Q3 		$453K Hold
6,537
– – 0.07% 206
2023
Q2 		$617K Hold
6,537
– – 0.09% 183
2023
Q1 		$541K Hold
6,537
– – 0.08% 199
2022
Q4 		$488K Hold
6,537
– – 0.07% 207
2022
Q3 		$540K Buy
+6,537
New +$629K 0.09% 189

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Romano Brothers & Co's EW Position: Q2 2026 in Review

Romano Brothers & Co held its Edwards Lifesciences (EW) position steady in Q2 2026 at 5,605 shares worth $507K. The position accounts for 0.05% of the portfolio, ranked #238.

Romano Brothers & Co first reported a position in EW in Q3 2022 and has held it in 16 quarters since. The position peaked at $617K in Q2 2023. 1,327 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Romano Brothers & Co held 5,605 shares of Edwards Lifesciences worth $507K as of Q2 2026.
  • Romano Brothers & Co left its Edwards Lifesciences share count unchanged in Q2 2026.
  • Edwards Lifesciences made up 0.05% of Romano Brothers & Co's portfolio in Q2 2026, its #238 holding.
  • Romano Brothers & Co first reported a position in Edwards Lifesciences in Q3 2022 and has held it in 16 quarters since.
  • Romano Brothers & Co's Edwards Lifesciences position peaked at $617K in Q2 2023.
  • 1,327 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Romano Brothers & Co's 13F filing for Q2 2026, filed 22 Jul 2026.